These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23178532)

  • 1. Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum.
    Jin J; Ma H; Xu L; An D; Sun S; Huang X; Kong W; Jiang C
    J Virol Methods; 2013 Feb; 187(2):362-7. PubMed ID: 23178532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71.
    Huang ML; Chiang PS; Luo ST; Liou GY; Lee MS
    J Virol Methods; 2010 Apr; 165(1):42-5. PubMed ID: 20036286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum.
    Arita M; Iwai M; Wakita T; Shimizu H
    Clin Vaccine Immunol; 2011 Nov; 18(11):1889-94. PubMed ID: 21880850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a coxsackievirus A16 neutralization test based on the enzyme-linked immunospot assay.
    Hou W; Yang L; He D; Zheng J; Xu L; Liu J; Liu Y; Zhao H; Ye X; Cheng T; Xia N
    J Virol Methods; 2015 Apr; 215-216():56-60. PubMed ID: 25704596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an efficient neutralization assay for Coxsackievirus A10.
    Liu D; Xu L; Zhu R; Yin Z; Lin Y; Hou W; Li S; He S; Cheng T; Xia N
    Appl Microbiol Biotechnol; 2019 Feb; 103(4):1931-1938. PubMed ID: 30617817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand.
    Lerdsamran H; Prasertsopon J; Mungaomklang A; Klinmalai C; Noisumdaeng P; Sangsiriwut K; Tassaneetrithep B; Guntapong R; Iamsirithaworn S; Puthavathana P
    Virol J; 2018 Oct; 15(1):158. PubMed ID: 30326914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of pan-neutralizing mouse monoclonal antibodies against enterovirus 71 and coxsackievirus A16].
    Jiang Z; Tian X; Zhang Y; Cheng Q; Lu X; Zhong B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jul; 37(7):645-650. PubMed ID: 34140076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants.
    Mao QY; Liao XY; Yu X; Li N; Zhu FC; Zeng Y; Liang ZL; Li FX; Wang JZ; Lu FM; Zhuang H
    Chin Med J (Engl); 2010 Jul; 123(13):1679-84. PubMed ID: 20819628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10.
    Li K; Dong F; Cui B; Cui L; Liu P; Ma C; Zheng H; Wu X; Liang Z
    Hum Vaccin Immunother; 2020 Jun; 16(6):1434-1440. PubMed ID: 31851566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China.
    Wang JX; Zhu SL; Wang J; Lin Y; Pei YW; Sun DP; Zhang Y; Wang XJ; Xu WB; Ding SJ
    PLoS One; 2016; 11(9):e0162373. PubMed ID: 27611441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
    Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
    Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
    Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a pseudovirus based assay for measuring neutralizing antibodies against coxsackievirus B5.
    Chen P; Wu X; Su Y; Hao X; Mao Q; Liang Z
    J Virol Methods; 2017 Aug; 246():21-26. PubMed ID: 28435072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71.
    Wu X; Mao Q; Yao X; Chen P; Chen X; Shao J; Gao F; Yu X; Zhu F; Li R; Li W; Liang Z; Wang J; Lu F
    PLoS One; 2013; 8(6):e64116. PubMed ID: 23755115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
    Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population.
    Tan S; Tan X; Sun X; Lu G; Chen CC; Yan J; Liu J; Xu W; Gao GF
    J Immunol; 2013 Aug; 191(4):1637-47. PubMed ID: 23863902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice.
    Jiang L; Fan R; Sun S; Fan P; Su W; Zhou Y; Gao F; Xu F; Kong W; Jiang C
    Vaccine; 2015 Nov; 33(48):6596-603. PubMed ID: 26529072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.